Cystinuria clinical trials at UCSF
1 in progress, 1 open to new patients
open to eligible people ages 18 years and up
This study evaluates how daily alpha lipoic acid supplementation affects cystine kidney stone recurrence. Half of the subjects will receive 1200 mg alpha lipoic acid orally daily for three years, while the other half will receive a placebo. The funding source for this clinical trial is FDA OOPD.
San Francisco, California